Jul 12, 2023 / 05:00PM GMT
Jenene Thomas - JTC Team, LLC - Moderator
Well, good afternoon, and thank you for joining us for our next company in the Virtual Investor Summer Spotlight Series. We are on day two. We've had an action-packed schedule and we have an exciting company, Ceapro Inc., going to be sort of the discussion next.
So my name is Jenene Thomas, I am CEO of JTC IR, and I will be the moderator for today's event. I am pleased to be joined by Gilles Gagnon, Chief Executive Officer of Ceapro; and Dr. Vincent Lee, Chief Operating Officer and Scientific Director of The Angiogenesis Foundation.
So before we get started, I want to inform our audience that Ceapro is publicly listed and trades on the TSX-V under the ticker CZO and the OTCQX under the ticker CRPOF. So during today's discussion, the company will be making forward-looking statements, and I encourage everyone to view the company's website at ceapro.com for the latest information. Gilles, Dr. Li, welcome. So happy to have you on our conference.
Gilles Gagnon - Ceapro Inc. - President & CEO
Thank you,
Ceapro Inc and Angiogenesis Foundation Inc at Virtual Investor: Summer Spotlight Series Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot